Protective Effects of Silymarin on Gentamicin-Induced Nephrotoxicity in Infectious Patients: A Randomized Double Blinded Placebo-Controlled Clinical Trial
暂无分享,去创建一个
S. A. Saadatjoo | A. Zarban | Meghdad Abdollahpour‐Alitappeh | Motahareh Mahi-birjand | I. Karimzadeh | M. Ziaee
[1] N. Bagheri,et al. Protective effects of pharmacological agents against aminoglycoside-induced nephrotoxicity: A systematic review , 2020, Expert opinion on drug safety.
[2] M. Nematbakhsh,et al. The Protective Role of Silymarin and Aerobic Exercise on Gentamicin-induced Nephrotoxicity , 2019, International journal of preventive medicine.
[3] M. Abedini,et al. Evaluation of vancomycin use in university-affiliated hospitals in Southern Khorasan Province (East Iran) based on HICPAC guidelines , 2019, Drug, healthcare and patient safety.
[4] B. Afşar,et al. Addition of silymarin to renin–angiotensin system blockers in normotensive patients with type 2 diabetes mellitus and proteinuria: a prospective randomized trial , 2017, International Urology and Nephrology.
[5] F. Doran,et al. Protective effect of alpha-linolenic acid on gentamicin-induced ototoxicity in mice , 2017, Somatosensory & motor research.
[6] Zhanjun Jia,et al. PEA3 protects against gentamicin nephrotoxicity: role of mitochondrial dysfunction. , 2017, American journal of translational research.
[7] O. Firuzi,et al. Effects of silymarin on biochemical and oxidative stress markers in end‐stage renal disease patients undergoing peritoneal dialysis , 2016, Hemodialysis international. International Symposium on Home Hemodialysis.
[8] Amir Rashidian,et al. Comparison of the Protective Effects of Melatonin and Silymarin Against Gentamicin-Induced Nephrotoxicity in Rats , 2016, Journal of evidence-based complementary & alternative medicine.
[9] K. Krause,et al. Aminoglycosides: An Overview. , 2016, Cold Spring Harbor perspectives in medicine.
[10] Farshad Roghani,et al. Silymarin for the Prevention of Contrast-Induced Nephropathy: A Placebo-Controlled Clinical Trial , 2016, International journal of preventive medicine.
[11] A. Abdollahi,et al. Effect of Silymarin Administration on Cisplatin Nephrotoxicity: Report from A Pilot, Randomized, Double‐Blinded, Placebo‐Controlled Clinical Trial , 2015, Phytotherapy research : PTR.
[12] P. Donnan,et al. Risk of AKI with gentamicin as surgical prophylaxis. , 2014, Journal of the American Society of Nephrology : JASN.
[13] H. Najafi,et al. Calcium dobesilate for prevention of gentamicin-induced nephrotoxicity in rats. , 2014, Iranian journal of kidney diseases.
[14] M. Nematbakhsh,et al. Protective Role of Silymarin and Deferoxamine Against Iron Dextran-induced Renal Iron Deposition in Male Rats , 2013, International journal of preventive medicine.
[15] B. Dormanesh,et al. Effect of addition of silymarin to renin-angiotensin system inhibitors on proteinuria in type 2 diabetic patients with overt nephropathy: a randomized, double-blind, placebo-controlled trial. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[16] M. Mashayekhi. Renoprotective effect of silymarin on gentamicin- induced nephropathy , 2012 .
[17] S. Veljković,et al. Salicylic Acid Attenuates Gentamicin-Induced Nephrotoxicity in Rats , 2012, TheScientificWorldJournal.
[18] H. Khalili,et al. Potential renoprotective effects of silymarin against nephrotoxic drugs: a review of literature. , 2012, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[19] H. Nasri,et al. Silymarin and diabetic nephropathy , 2012, Journal of renal injury prevention.
[20] K. Wellington,et al. Silymarin: A Review of its Clinical Properties in the Management of Hepatic Disorders , 2012, BioDrugs.
[21] H. Ahmadvand,et al. Inhibitory effect of olive leaf extract on gentamicin-induced nephrotoxicity in rats. , 2012, Iranian journal of kidney diseases.
[22] Mushir M. Ali,et al. Reassessing bioavailability of silymarin. , 2011, Alternative medicine review : a journal of clinical therapeutic.
[23] M. Moshiri,et al. “Silymarin”, a Promising Pharmacological Agent for Treatment of Diseases , 2011, Iranian journal of basic medical sciences.
[24] J. Roozbeh,et al. Comparative Effects of Silymarin and Vitamin E Supplementation on Oxidative Stress Markers, and Hemoglobin Levels Among Patients on Hemodialysis , 2011, Renal failure.
[25] R. Capasso,et al. Milk thistle in liver diseases: past, present, future , 2010, Phytotherapy research : PTR.
[26] K. Kelly,et al. A randomized, controlled, double‐blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL) , 2010, Cancer.
[27] M. Sayed-Ahmed,et al. Increased urinary losses of carnitine and decreased intramitochondrial coenzyme A in gentamicin-induced acute renal failure in rats. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[28] G. Mohamed,et al. Protective effect of quercetin against gentamicin-induced nephrotoxicity in rats. , 2009, Biological & pharmaceutical bulletin.
[29] D. Batlle,et al. Clinical Nephrotoxins: Renal Injury from Drugs and Chemicals , 2008 .
[30] Asad U. Khan,et al. Aminoglycosides versus bacteria--a description of the action, resistance mechanism, and nosocomial battleground. , 2008, Journal of biomedical science.
[31] A. Shahriari,et al. Effect of silymarin and vitamin E on gentamicin-induced nephrotoxicity in dogs. , 2007, Journal of veterinary pharmacology and therapeutics.
[32] K. Pradeep,et al. Silymarin modulates the oxidant-antioxidant imbalance during diethylnitrosamine induced oxidative stress in rats. , 2007, European journal of pharmacology.
[33] T. Butler,et al. Treatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[34] V. Křen,et al. Silybin and silymarin--new effects and applications. , 2005, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.
[35] A. Whelton. The aminoglycosides. , 1984, Clinical orthopaedics and related research.